# FDA Inspection 989064 - Max Spine, LLC - August 18, 2016

Source: https://www.keypedia.com/records/fda_inspections/max-spine-llc/4f1ab78e-57bd-411a-9a6e-923db0e71b7a
Source feed: FDA_Inspections

> FDA Inspection 989064 for Max Spine, LLC on August 18, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 989064
- Company Name: Max Spine, LLC
- Inspection Date: 2016-08-18
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 865391 - 2014-01-27](https://www.keypedia.com/records/fda_inspections/max-spine-llc/73c66a66-c148-4e54-8e2f-9a75a2fd425b)
- [FDA Inspection 796336 - 2012-08-27](https://www.keypedia.com/records/fda_inspections/max-spine-llc/ae6a1481-52ba-43fa-9fa9-7c1e69fd1061)

Company: https://www.keypedia.com/companies/max-spine-llc/3578f2c7-fd1c-45a1-a803-506ca2687501

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d